n/a
How funds with Inflammatory & Immune exposure have returned on average.
Average 1Y return to September 2026 end, GBP net total return.
Source: FE fundinfo. Past performance is not a reliable guide to future returns.
No performance series available for this category
We do not yet have enough fund data to summarise this category.
Largest Inflammatory & Immune funds
The biggest funds with this exposure, to open or compare.
No funds with enough data in this view.
Top Inflammatory & Immune funds by assets under management, one share class per fund.
Inflammatory & Immune holdings
The positions held by the most funds with this exposure.
No position is held by three or more of these funds.
Shown when at least 3 funds hold the top position. Bar: average share among holders.
All funds with Inflammatory & Immune exposure
Largest by size first, one share class per fund. Open any fund for its holdings, performance and allocation breakdown.